Global Atezolizumab Market Poised to Soar to US$ 10.67 Billion by 2032

added blog Other

2025-11-25 07:41:33 -

Atezolizumab market, a cornerstone in immuno-oncology, is projected to expand at a CAGR of 16.5% between 2024 and 2032, growing from US$ 2.70 billion in 2023 to US$ 10.67 billion by 2032. The strong forecast reflects growing use in cancer treatment especially in non-small cell lung cancer (NSCLC) and the increasing momentum of regulatory approvals, combination therapies, and penetration into...

0 Comments 0 Shares 88 Views 0 Reviews